TSBX: Turnstone Biologics Corp. Stock

by  •  • Comments Off on TSBX: Turnstone Biologics Corp. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 11.08
Enterprise Value ($M) -13.05
Book Value ($M) 43.64
Book Value / Share 1.89
Price / Book 0.25
NCAV ($M) 36.30
NCAV / Share 1.57
Price / NCAV 0.31

Profitability (mra)
Return on Invested Capital (ROIC) -1.64
Return on Assets (ROA) -0.66
Return on Equity (ROE) -0.65

Liquidity (mrq)
Quick Ratio 3.75
Current Ratio 3.75

Balance Sheet (mrq) ($M)
Current Assets 51.14
Assets 58.48
Liabilities 14.84
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
05-31 13G/A Langer Timothy 4.30 -23.17
04-29 13G/A Fmr Llc 5.99 -45.56

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-14 17,604 139,867 12.59
2025-01-13 62,275 163,067 38.19
2025-01-10 67,979 222,259 30.59

(click for more detail)

Similar Companies
TNGX – Tango Therapeutics, Inc. TRDA – Entrada Therapeutics, Inc.
TRVI – Trevi Therapeutics, Inc. TVTX – Travere Therapeutics, Inc.
URGN – UroGen Pharma Ltd.


Financial data and stock pages provided by
Fintel.io